Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113185478B reveals a novel ethylenediamine-based route for N-Boc-piperazine, offering superior purity and significant cost reduction for pharmaceutical manufacturing.
Patent CN101717392A details a novel rotigotine synthesis using chiral phosphoric acid resolution, offering high optical purity and cost reduction in API manufacturing.
Patent CN112479876A reveals a novel chiral resolution route for oxazepine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101580473B reveals a mild 3-step synthesis for N-methyl p-nitroaniline. Achieve >98% purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Novel copper-catalyzed hydroamination method offers high atom economy and mild conditions for scalable pharmaceutical intermediate production.
Novel C-H amination method for gamma/delta-lactams offers high selectivity and cost-effective routes for complex API intermediates.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN112574112B details a green oxidative synthesis for N-substituted 2H-indazoles. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN111470983A details a high-yield synthesis of bromhexine hydrochloride. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN110003275A details a high-yield synthesis of 4,6-bis(diphenylphosphino)phenazine ligands. Discover cost-effective manufacturing and supply chain advantages for industrial catalysis.
Novel aluminum catalyst enables anti-Markovnikov hydroamination with high yield. Reduces cost and improves supply chain reliability for amine synthesis.
Patent CN103214407B details silver-catalyzed sp3 C-H amination for tetrahydropyrrole derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Discover the atom-economical synthesis of 1,5-benzodiazepine derivatives using gold catalysis. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN117865874A details Pd-catalyzed olefin C-H amination for high-purity tetrahydroindole derivatives, offering scalable solutions for pharmaceutical intermediates manufacturing.
Patent CN112441934B discloses a mild copper-catalyzed method for halogenated oxaallylamine synthesis, offering reliable supply and cost reduction in API manufacturing.
Novel copper-catalyzed method for halogenated oxaallylamines. Reduces steps, improves yield for beta-blocker intermediates. Ideal for API manufacturing cost reduction.
Patent CN119060059B details a novel three-step synthesis for Ritlecitinib Tosylate offering enhanced purity and scalable manufacturing efficiency for global pharmaceutical supply chains.
Novel cobalt method replaces rhodium and palladium for carbazole synthesis, offering significant cost reduction and high yields for pharmaceutical intermediates.
Patent CN121426782A details a novel Pd-catalyzed route for 2-aminoindole derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.